Evidence map›Paper›PMID 37168112›Full record

ArticleFrontiers in microbiology2023

Esra Ekinci, Laura Willen, Juan Pablo Rodriguez Ruiz, Kirsten Maertens, Liesbet Van Heirstraeten, Gabriela Serrano, Magali Wautier, Ariane Deplano, Herman Goossens, Pierre Van Damme and 4 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Extensively drug-resistant Haemophilus influenzae isolated in Geneva, Switzerland.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  5. Monitoring of Haemophilus influenzae isolated from carriage, lower respiratory tract infections and blood over a six-month period in Belgium.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Esra EkinciCentre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.
Laura WillenCentre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.
Juan Pablo Rodriguez RuizLaboratory of Medical Microbiology, University of Antwerp, Wilrijk, Belgium.
Kirsten MaertensCentre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.
Liesbet Van HeirstraetenLaboratory of Medical Microbiology, University of Antwerp, Wilrijk, Belgium.
Gabriela SerranoNational Reference Centre for Haemophilus influenzae, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
Magali WautierNational Reference Centre for Haemophilus influenzae, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
Ariane DeplanoNational Reference Centre for Haemophilus influenzae, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
Herman GoossensLaboratory of Medical Microbiology, University of Antwerp, Wilrijk, Belgium.
Pierre Van DammeCentre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.
Philippe BeutelsCentre for Health Economics Research and Modelling Infectious Diseases, University of Antwerp, Wilrijk, Belgium.
Surbhi Malhotra-KumarLaboratory of Medical Microbiology, University of Antwerp, Wilrijk, Belgium.
Delphine MartinyNational Reference Centre for Haemophilus influenzae, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
Heidi TheetenCentre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Non-typeable Methods: Nasopharyngeal swab samples were taken over a three-year period (2016-2018) from 336 children (6-30 months of age) attending daycare centers (DCCs) in Belgium, and from 218 children with acute otitis media (AOM). Biotype, serotype, and antibiotic resistance of Results: Overall, NTHi was most frequently present in both carriage (DCC, AOM) and invasive group. This was followed by serotype "f" (2.2%) and "e" (1.4%) in carriage, and "b" (16.0%), "f" (11.7%), and "a" (4.3%) in invasive strains. Biotype II was most prevalent in all studied groups, followed by biotype III in carriage and I in invasive strains. Strains from both groups showed highest resistance to ampicillin (26.7% in carriage vs. 18.1% in invasive group). A higher frequency of Conclusion: In both groups, NTHi was most frequently circulating, while specific encapsulated serotypes for carriage and invasive group were found. Biotypes I, II and III were more frequently present in the carriage and invasive group. The carriage group had a higher resistance-frequency to the analyzed antibiotics than the invasive group. Interestingly, a higher degree of

Indexed as

antibiotic susceptibility testingbiotypeschildrenHaemophilus influenzaemutationsserotypes

Identifiers

PMID37168112
PMCPMC10164969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.